乙-L-卡尼丁 (LAC) 的神经心理药理学:基本,转化和治疗影响
Benedetta Bigio1, Shofiul Azam1,2, Aleksander A Mathé3
1Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
Discover mental health
|January 3, 2024
概括
乙-L-卡尼丁 (LAC) 是线粒体的代谢物,影响大脑的可塑性,可以治疗抑郁症和阿尔茨海默病. 促进LAC新陈代谢可以对抗氧化应激,胰岛素抵抗和神经炎症.
科学领域:
- 神经科学是一个神经科学.
- 线粒体的新陈代谢
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 乙-L-卡尼丁 (LAC) 是一个关键的线粒体代谢物,参与脂肪酸氧化.
- LAC被认为是一种影响大脑可塑性的表观遗传调节器.
- 功能障碍的LAC新陈代谢与阿尔茨海默病和严重抑郁症有关.
研究的目的:
- 研究LAC在表观遗传机制和大脑可塑性中的作用.
- 探索LAC作为抑郁症和阿尔茨海默病的治疗点.
- 阐明线粒体代谢对神经系统疾病的影响.
主要方法:
- 临床前研究检查LAC对神经元功能的影响.
- 分析与线粒体代谢相关的表观遗传修饰.
- 研究氧化应激,炎症和胰岛素抵抗路径的调节.
主要成果:
- 促进线粒体LAC新陈代谢迅速调节表观遗传和谷物质功能.
- 使用LAC可以防止氧化应激和胰岛素抵抗.
- 通过神经元中NFkB信号的减少,观察到神经炎症的减少.
结论:
- 涉及LAC的线粒体信号通路为大脑可塑性提供了潜在的治疗点.
- 针对LAC代谢可能为特定的抑郁症和阿尔茨海默病的临床表型提供新的干预措施.
- 线粒体健康对于神经元功能和对神经疾病的抵抗力至关重要.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
127
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
127
Phase II Reactions: Acetylation Reactions
229
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
229
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Alzheimer's Disease: Overview
491
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
491
Long-term Potentiation
55.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
55.2K
Role of Neurotransmitters in Memory
564
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
564


